- Home
- ALEC vs NUW Comparison
ALEC vs NUW Comparison
Compare ALEC & NUW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALEC | NUW |
|---|---|---|
| Founded | 2013 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 241.2M | 259.6M |
| IPO Year | 2019 | 2008 |
Fundamental Metrics
Financial Performance| Metric | ALEC | NUW |
|---|---|---|
| Price | $2.00 | $14.38 |
| Analyst Decision | Hold | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $3.33 | N/A |
| AVG Volume (30 Days) | ★ 894.3K | 32.0K |
| Earning Date | 05-25-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $21,045,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $45.24 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.87 | $13.04 |
| 52 Week High | $3.40 | $14.62 |
Technical Indicators
Market Signals| Indicator | ALEC | NUW |
|---|---|---|
| Relative Strength Index (RSI) | 47.91 | 47.30 |
| Support Level | $1.22 | $14.17 |
| Resistance Level | $2.02 | $14.40 |
| Average True Range (ATR) | 0.19 | 0.11 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 19.72 | 31.03 |
Price Performance
Historical ComparisonAbout ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.
About NUW Nuveen AMT-Free Municipal Value Fund
Nuveen AMT-Free Municipal Value Fund is a diversified closed-end management investment company. The Fund's primary investment objective is to provide current income exempt from regular federal income tax. The Fund's secondary investment objective is to enhance portfolio value and total return.